approval · primary record
TREMELIMUMAB-ACTL
FDA · BLA · 2026-08-31
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-31 |
| Brand | IMJUDO |
| Sponsor | ASTRAZENECA AB |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:08.711Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TREMELIMUMAB-ACTL:2026-08-31
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.